| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Cost of revenue | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Gross profit | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Operating expenses: | |||||||||
Research and development | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Sales and marketing | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
General and administrative | |||||||||
21,411 | 17,431 | 2,981 | 6,189 | 5,860 | 2,394 | 1,879 | 0 | 0 | 0 |
Total operating expenses | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Loss from operations | |||||||||
-10,802 | -2,419 | -2,981 | -3,608 | -3,279 | -2,394 | -1,879 | 0 | 0 | 0 |
Other income, net | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Financial income (expense), net | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Foreign currency income (loss) | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Interest income on cash and marketable securities held in Trust Account | |||||||||
- | - | 2,648 | 2,931 | 2,812 | 2,513 | 1,814 | 0 | 0 | 0 |
Loss before income tax expense (benefit) | |||||||||
-11,351 | -3,239 | -333 | -1,584 | -1,373 | 119 | -64 | 0 | 0 | 0 |
Income tax expense (benefit) | |||||||||
1,605 | 2,273 | 753 | 718 | 710 | 803 | 600 | 0 | 0 | 0 |
Net loss | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Net loss attributable to the owners of the parent | |||||||||
- | -5,512 | -1,086 | -1,170 | -952 | -683 | -665 | 0 | 0 | 0 |
Net loss per common share basic and diluted | |||||||||
-0.44 | -0.08 | -0.17 | -0.10 | -0.13 | -0.14 | -0.25 | -0.05 | -0.06 | -0.04 |
Weighted-average shares used in computing net loss per common share basic and diluted | |||||||||
19,979 | 33,642 | -2,154 | 4,238 | 10,687 | 4,056 | 4,059 | 4,033 | 4,038 | 4,062 |